Abstract
Lung injury resulting from inhaled toxins continues to be associated with significant morbidity and mortality. Inhalation injury, when combined with epidermal burns, increases fluid resuscitation requirements. While cutaneous burns can be excised and grafted, pulmonary mucosa must be protected from secondary injury caused by mechanical ventilation, resuscitation, and infections to allow for host repair mechanisms. Many of the consequences of smoke inhalation result from activation of an inflammatory response with immune mediators which are not completely understood. Morbidity from smoke inhalation results from thermal injury and inhaled toxins.
Keywords: Burn, inhalation, airway, ARDS, bronchoscopy.
Current Respiratory Medicine Reviews
Title:Inhalational Injury: A Brief Review of Pathophysiology, Diagnosis and Treatment
Volume: 11 Issue: 1
Author(s): Delphine Engel and Riyad Karmy-Jones
Affiliation:
Keywords: Burn, inhalation, airway, ARDS, bronchoscopy.
Abstract: Lung injury resulting from inhaled toxins continues to be associated with significant morbidity and mortality. Inhalation injury, when combined with epidermal burns, increases fluid resuscitation requirements. While cutaneous burns can be excised and grafted, pulmonary mucosa must be protected from secondary injury caused by mechanical ventilation, resuscitation, and infections to allow for host repair mechanisms. Many of the consequences of smoke inhalation result from activation of an inflammatory response with immune mediators which are not completely understood. Morbidity from smoke inhalation results from thermal injury and inhaled toxins.
Export Options
About this article
Cite this article as:
Engel Delphine and Karmy-Jones Riyad, Inhalational Injury: A Brief Review of Pathophysiology, Diagnosis and Treatment, Current Respiratory Medicine Reviews 2015; 11 (1) . https://dx.doi.org/10.2174/1573398X1101150706144638
DOI https://dx.doi.org/10.2174/1573398X1101150706144638 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Sub-Chronic Exposure of Non-Observable Adverse Effect Dose of Terbufos Sulfone: Neuroinflammation in Diabetic and Non-Diabetic Rats
CNS & Neurological Disorders - Drug Targets Schizophrenia: A Systematic Review of the Disease State, Current Therapeutics and their Molecular Mechanisms of Action
Current Medicinal Chemistry TiO2-Nanowired Delivery of Mesenchymal Stem Cells Thwarts Diabetes- Induced Exacerbation of Brain Pathology in Heat Stroke: An Experimental Study in the Rat Using Morphological and Biochemical Approaches
CNS & Neurological Disorders - Drug Targets Neuroinflammation as a Common Mechanism Associated with the Modifiable Risk Factors for Alzheimer’s and Parkinson’s Diseases
Current Aging Science Novel Therapies for Schizophrenia: Understanding the Glutamatergic Synapse and Potential Targets for Altering N-methyl-D-aspartate Neurotransmission
Recent Patents on CNS Drug Discovery (Discontinued) The Role of Microglial Cell Subsets in Alzheimers Disease
Current Alzheimer Research The Blood Brain Barrier and its Role in Alzheimer's Therapy: An Overview
Current Drug Targets 25OH-Vitamin D3 Levels in Obesity and Metabolic Syndrome—Unaltered in Young and not Correlated to Carotid IMT in All Ages
Current Pharmaceutical Design Reduced Risk of Incident AD with Elective Statin Use in a Clinical Trial Cohort
Current Alzheimer Research In Silico Dynamic Molecular Interaction Networks for the Discovery of New Therapeutic Targets
Current Pharmaceutical Design Practical Recommendations for Familial Combined Hyperlipidemia Diagnosis and Management: An Update
Vascular Disease Prevention (Discontinued) Targeted Hydrolysis of Beta-Amyloid with Engineered Antibody Fragments
Current Alzheimer Research Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation
Current Alzheimer Research Quantitative and Mechanistic Studies of Aβ Immunotherapy
CNS & Neurological Disorders - Drug Targets Discovery of Anti-Alzheimer Agents: Current Ligand-Based Approaches toward the Design of Acetylcholinesterase Inhibitors
Mini-Reviews in Medicinal Chemistry Heterocyclic Secretase Inhibitors for the Treatment of Alzheimer’s Disease: An Overview
Central Nervous System Agents in Medicinal Chemistry The Role of Neuronal Insulin/Insulin-Like Growth Factor-1 Signaling for the Pathogenesis of Alzheimer’s Disease: Possible Therapeutic Implications
CNS & Neurological Disorders - Drug Targets Measuring Alzheimer Disease Progression with Transition Probabilities: Estimates from NACC-UDS
Current Alzheimer Research Advanced Drug Delivery of N-Acetylcarnosine (N-Acetyl-beta-alanyl-Lhistidine), Carcinine (Beta-alanylhistamine) and L-carnosine (Beta-alanyl- L-histidine) in Targeting Peptide Compounds as Pharmacological Chaperones for Use in Tissue Engineering, Human Disease Management and Therapy: From in vitro to the Clinic
Recent Patents on Drug Delivery & Formulation Tribute to Prof. Gerald Farin: Remembering A Geometric Modeling Researcher and Educator
Neuroscience and Biomedical Engineering (Discontinued)